# Evofem Biosciences Inc. – FDA Inspection, Sep 11, 2026

Source: https://www.keypedia.com/records/fda_inspections/evofem-biosciences-inc/26179937-7cf2-4719-ad64-c79c76cdc38d
Source feed: FDA_Inspections

> FDA inspection 1300796 of Evofem Biosciences Inc., September 11, 2026. 2 citations under 21 CFR part 314. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1300796
- Company Name: Evofem Biosciences Inc.
- Inspection Date: 2026-09-11
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 940944 - 2015-08-28
- FDA Inspection 808507 - 2012-11-28

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jose-a-leyva/0c0ffdd3-cd41-4e30-bf61-e96f62a58921)

Company: https://www.keypedia.com/companies/evofem-biosciences-inc/852d689d-a97e-4faa-8618-278de9b4faae

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b